Drug Shortage Report for TRIATEC-8
| Report ID | 65932 |
| Drug Identification Number | 00852163 |
| Brand name | TRIATEC-8 |
| Common or Proper name | Triatec-8 |
| Company Name | LABORATOIRE RIVA INC. |
| Market Status | DORMANT |
| Active Ingredient(s) | ACETAMINOPHEN CODEINE PHOSPHATE CAFFEINE |
| Strength(s) | 325MG 8MG 15MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30 & 100 & 200 |
| ATC code | N02AJ |
| ATC description | OPIOIDS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2018-10-31 |
| Actual start date | 2018-10-31 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2018-11-01 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 660 BOUL. INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2018-11-01 | English | Compare |
| v2 | 2018-10-31 | French | Compare |
| v1 | 2018-10-31 | English | Compare |
Showing 1 to 3 of 3